跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
瑞易宁 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Glipizide Extended Release Tablets
Approved
化学药品
Glipizide Extended Release Tablets
辉瑞
🇨🇳 National Medical Products Administration
Approval Date
Oct 14, 2024
Approval ID
8iXrnCtJ5fe
Company
辉瑞
Type
化学药品
Approval Details
Approval Id
8iXrnCtJ5fe
Approval Number
国药准字HJ20160140
Generic Name
格列吡嗪控释片
Generic Name En
Glipizide Extended Release Tablets
Trade Name
瑞易宁
Drug Type
化学药品
Dosage Form
片剂
Strength
5mg
Reg Date
2024-10-14
Expired Date
2029-10-13
Company Name
辉瑞
Production Company Name
Viatris Pharmaceuticals LLC
Company Detail Path
/organization/pfizer-cdr-cad-hedged
Production Company Detail Path
/organization/viatris-pharmaceuticals-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Oct 14, 2024
Approval ID
8iXrnCtJ5fe
Type
化学药品
Back to NMPA Approvals